The CDK4/6 inhibitors biomarker landscape: The most relevant biomarkers of response or resistance for further research and potential clinical utility
Gabriele Antonarelli, Beatrice Taurelli Salimbeni, Antonio Marra, Angela Espósito, Marzia Locatelli, Dario Trapani, Carlo Pescia, Nicola Fusco, Giuseppe Curigliano, Carmen Criscitiello
Topics & Concepts
BiomarkerMedicineAcquired resistanceOncologyHuman Epidermal Growth Factor Receptor 2Cyclin-dependent kinase 4CancerBioinformaticsInternal medicineBreast cancerBiologyCell cycleCyclin-dependent kinase 2BiochemistryAdvanced Breast Cancer TherapiesChronic Lymphocytic Leukemia ResearchHER2/EGFR in Cancer Research